Healthcare provider profile · identity verified

Alexzavier Colon-Rivera, MD

General Practice · OCALA, FL · NPI 1497384846

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	195
Rosuvastatin Calcium	Rosuvastatin Calcium	387	154
Lisinopril	Lisinopril	331	138
Losartan Potassium	Losartan Potassium	312	116
Levothyroxine Sodium	Levothyroxine Sodium	300	111
Amlodipine Besylate	Amlodipine Besylate	261	101
Metformin Hcl	Metformin Hcl	234	88
Gabapentin	Gabapentin	203	88
Omeprazole	Omeprazole	192	76
Furosemide	Furosemide	165	64
Trazodone Hcl	Trazodone Hcl	152	56
Metoprolol Succinate	Metoprolol Succinate	150	56
Hydrochlorothiazide	Hydrochlorothiazide	149	57
Pantoprazole Sodium	Pantoprazole Sodium	128	53
Metoprolol Tartrate	Metoprolol Tartrate	127	51
Simvastatin	Simvastatin	117	48
Baclofen	Baclofen	116	57
Methylprednisolone	Methylprednisolone	115	100
Albuterol Sulfate Hfa	Albuterol Sulfate	108	52
Azithromycin	Azithromycin	108	96
Tamsulosin Hcl	Tamsulosin Hcl	108	44
Meloxicam	Meloxicam	104	48
Montelukast Sodium	Montelukast Sodium	99	39
Sertraline Hcl	Sertraline Hcl	85	31
Glipizide	Glipizide	82	32
Famotidine	Famotidine	76	42
Glipizide Er	Glipizide	72	32
Eliquis	Apixaban	71	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	24
Pravastatin Sodium	Pravastatin Sodium	69	24
Carvedilol	Carvedilol	67	26
Tizanidine Hcl	Tizanidine Hcl	60	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	21
Alendronate Sodium	Alendronate Sodium	58	27
Buspirone Hcl	Buspirone Hcl	56	23
Duloxetine Hcl	Duloxetine Hcl	56	19
Glimepiride	Glimepiride	54	22
Fluoxetine Hcl	Fluoxetine Hcl	53	17
Fluticasone Propionate	Fluticasone Propionate	53	24
Tramadol Hcl	Tramadol Hcl	50	22
Clopidogrel	Clopidogrel Bisulfate	49	23
Pioglitazone Hcl	Pioglitazone Hcl	47	18
Prednisone	Prednisone	47	38
Hydroxyzine Hcl	Hydroxyzine Hcl	46	19
Metformin Hcl Er	Metformin Hcl	46	15
Allopurinol	Allopurinol	45	18
Ezetimibe	Ezetimibe	45	20
Potassium Chloride	Potassium Chloride	45	15
Farxiga	Dapagliflozin Propanediol	44	16
Escitalopram Oxalate	Escitalopram Oxalate	43	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	21
Finasteride	Finasteride	37	13
Alprazolam	Alprazolam	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	22
Hydralazine Hcl	Hydralazine Hcl	36	15
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Jardiance	Empagliflozin	34	16
Vitamin D2	Ergocalciferol (Vitamin D2)	34	16
Dicyclomine Hcl	Dicyclomine Hcl	33	18
Cephalexin	Cephalexin	32	30
Clonazepam	Clonazepam	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Atenolol	Atenolol	31	12
Fenofibrate	Fenofibrate Nanocrystallized	30	12
Valsartan	Valsartan	30	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	20
Paroxetine Hcl	Paroxetine Hcl	29	11
Pregabalin	Pregabalin	29	14
Celecoxib	Celecoxib	28	13
Ondansetron Hcl	Ondansetron Hcl	27	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	12
Mirtazapine	Mirtazapine	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Spironolactone	Spironolactone	25	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Bupropion Xl	Bupropion Hcl	24	11
Lorazepam	Lorazepam	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	14
Citalopram Hbr	Citalopram Hydrobromide	23	13
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	14
Nifedipine Er	Nifedipine	22	suppressed
Temazepam	Temazepam	22	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	16
Clonidine Hcl	Clonidine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amoxicillin	Amoxicillin	15	15
Doxycycline Monohydrate	Doxycycline Monohydrate	15	13
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fluconazole	Fluconazole	15	12
Levetiracetam	Levetiracetam	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	13
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Latanoprost	Latanoprost	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error